NanoCarrier Co., Ltd. (4571.T)
JPY 150.0
(-1.96%)
JPY 150.0
(-1.96%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -466.34 Million JPY | 72.61% |
| 2022 | -1.7 Billion JPY | 28.91% |
| 2021 | -2.39 Billion JPY | 38.46% |
| 2020 | -3.89 Billion JPY | 12.95% |
| 2019 | -4.47 Billion JPY | -113.73% |
| 2018 | -2.09 Billion JPY | -72.26% |
| 2017 | -1.21 Billion JPY | 82.45% |
| 2016 | -6.92 Billion JPY | 23.79% |
| 2015 | -9.08 Billion JPY | 33.55% |
| 2014 | -13.66 Billion JPY | -107.01% |
| 2013 | -6.6 Billion JPY | -64.62% |
| 2012 | -4.01 Billion JPY | -240.97% |
| 2011 | -1.17 Billion JPY | 33.44% |
| 2010 | -1.76 Billion JPY | -171.23% |
| 2009 | -651.52 Million JPY | 28.78% |
| 2008 | -914.86 Million JPY | 29.75% |
| 2007 | -1.3 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.89 Billion JPY | -305.71% |
| 2023 Q3 | -1.91 Billion JPY | -4.77% |
| 2023 FY | -466.34 Million JPY | 72.61% |
| 2023 Q4 | -466.34 Million JPY | 75.69% |
| 2023 Q1 | -1.81 Billion JPY | -6.68% |
| 2023 Q2 | -1.83 Billion JPY | -0.79% |
| 2022 Q4 | -1.7 Billion JPY | 18.52% |
| 2022 Q3 | -2.08 Billion JPY | -30.32% |
| 2022 FY | -1.7 Billion JPY | 28.91% |
| 2022 Q1 | -1.94 Billion JPY | 18.85% |
| 2022 Q2 | -1.6 Billion JPY | 17.49% |
| 2021 Q2 | -2.67 Billion JPY | 10.03% |
| 2021 Q4 | -2.39 Billion JPY | 4.66% |
| 2021 FY | -2.39 Billion JPY | 38.46% |
| 2021 Q1 | -2.97 Billion JPY | 23.47% |
| 2021 Q3 | -2.51 Billion JPY | 6.26% |
| 2020 FY | -3.89 Billion JPY | 12.95% |
| 2020 Q1 | -3.2 Billion JPY | 28.27% |
| 2020 Q2 | -3.04 Billion JPY | 5.06% |
| 2020 Q3 | -4.24 Billion JPY | -39.55% |
| 2020 Q4 | -3.89 Billion JPY | 8.4% |
| 2019 Q1 | -4.58 Billion JPY | -119.03% |
| 2019 Q3 | -6.34 Billion JPY | 3.3% |
| 2019 Q4 | -4.47 Billion JPY | 29.57% |
| 2019 FY | -4.47 Billion JPY | -113.73% |
| 2019 Q2 | -6.56 Billion JPY | -43.28% |
| 2018 Q1 | -558.42 Million JPY | 54.01% |
| 2018 Q3 | -709.09 Million JPY | 31.41% |
| 2018 Q4 | -2.09 Billion JPY | -194.98% |
| 2018 FY | -2.09 Billion JPY | -72.26% |
| 2018 Q2 | -1.03 Billion JPY | -85.13% |
| 2017 Q2 | -5.13 Billion JPY | 10.2% |
| 2017 Q4 | -1.21 Billion JPY | 54.15% |
| 2017 FY | -1.21 Billion JPY | 82.45% |
| 2017 Q1 | -5.71 Billion JPY | 17.45% |
| 2017 Q3 | -2.64 Billion JPY | 48.37% |
| 2016 Q3 | -7.53 Billion JPY | 2.01% |
| 2016 FY | -6.92 Billion JPY | 23.79% |
| 2016 Q1 | -8.8 Billion JPY | 3.04% |
| 2016 Q4 | -6.92 Billion JPY | 8.17% |
| 2016 Q2 | -7.69 Billion JPY | 12.66% |
| 2015 Q2 | -12.83 Billion JPY | 5.02% |
| 2015 Q1 | -13.51 Billion JPY | 1.11% |
| 2015 FY | -9.08 Billion JPY | 33.55% |
| 2015 Q3 | -11.77 Billion JPY | 8.26% |
| 2015 Q4 | -9.08 Billion JPY | 22.88% |
| 2014 Q4 | -13.66 Billion JPY | -5.7% |
| 2014 Q3 | -12.92 Billion JPY | -33.03% |
| 2014 FY | -13.66 Billion JPY | -107.01% |
| 2014 Q1 | -9.51 Billion JPY | -44.12% |
| 2014 Q2 | -9.71 Billion JPY | -2.15% |
| 2013 Q1 | -3.97 Billion JPY | 0.77% |
| 2013 FY | -6.6 Billion JPY | -64.62% |
| 2013 Q2 | -4.71 Billion JPY | -18.49% |
| 2013 Q3 | -7.18 Billion JPY | -52.47% |
| 2013 Q4 | -6.6 Billion JPY | 8.17% |
| 2012 FY | -4.01 Billion JPY | -240.97% |
| 2012 Q1 | -968.35 Million JPY | 17.67% |
| 2012 Q2 | -1.31 Billion JPY | -35.76% |
| 2012 Q3 | -3 Billion JPY | -128.32% |
| 2012 Q4 | -4.01 Billion JPY | -33.61% |
| 2011 Q4 | -1.17 Billion JPY | 32.01% |
| 2011 Q3 | -1.72 Billion JPY | -18.96% |
| 2011 Q1 | -1.6 Billion JPY | 8.94% |
| 2011 FY | -1.17 Billion JPY | 33.44% |
| 2011 Q2 | -1.45 Billion JPY | 9.64% |
| 2010 Q2 | -620.7 Million JPY | 5.71% |
| 2010 Q3 | -1.21 Billion JPY | -95.29% |
| 2010 Q4 | -1.76 Billion JPY | -45.78% |
| 2010 Q1 | -658.32 Million JPY | -1.04% |
| 2010 FY | -1.76 Billion JPY | -171.23% |
| 2009 FY | -651.52 Million JPY | 28.78% |
| 2009 Q3 | -624.27 Million JPY | 0.0% |
| 2009 Q4 | -651.52 Million JPY | -4.36% |
| 2008 Q3 | -962.53 Million JPY | 0.0% |
| 2008 FY | -914.86 Million JPY | 29.75% |
| 2008 Q4 | -914.86 Million JPY | 4.95% |
| 2007 FY | -1.3 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 162.786% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | 58.874% |
| GNI Group Ltd. | -17.93 Billion JPY | 97.4% |
| Linical Co., Ltd. | -4.46 Billion JPY | 89.551% |
| Trans Genic Inc. | -221.16 Million JPY | -110.855% |
| MEDINET Co., Ltd. | -4.39 Billion JPY | 89.387% |
| Soiken Holdings Inc. | -4.79 Billion JPY | 90.264% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 132.531% |
| AnGes, Inc. | -3.79 Billion JPY | 87.72% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -10.822% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 101.872% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | 6.385% |
| Carna Biosciences, Inc. | -2.7 Billion JPY | 82.767% |
| CanBas Co., Ltd. | -1.88 Billion JPY | 75.302% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | 52.517% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | 86.272% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | 54.923% |
| Kidswell Bio Corporation | 343.58 Million JPY | 235.728% |
| PeptiDream Inc. | 3.29 Billion JPY | 114.166% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | 52.051% |
| Ribomic Inc. | -2.09 Billion JPY | 77.79% |
| SanBio Company Limited | -3.78 Billion JPY | 87.694% |
| Healios K.K. | -2.19 Billion JPY | 78.706% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | 50.644% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -2.62 Billion JPY | 82.229% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | 67.091% |
| StemRIM | -8.41 Billion JPY | 94.455% |
| CellSource Co., Ltd. | -4.68 Billion JPY | 90.043% |
| FunPep Company Limited | -1.79 Billion JPY | 73.996% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | 78.172% |
| Stella Pharma Corporation | -1.11 Billion JPY | 58.34% |
| TMS Co., Ltd. | -3.44 Billion JPY | 86.469% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | 91.606% |
| Cuorips Inc. | -5.56 Billion JPY | 91.614% |
| K Pharma,Inc. | -3.26 Billion JPY | 85.723% |
| Takara Bio Inc. | -32.2 Billion JPY | 98.552% |
| ReproCELL Incorporated | -2.93 Billion JPY | 84.133% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | 29.444% |
| StemCell Institute Inc. | -2.83 Billion JPY | 83.561% |
| Japan Tissue Engineering Co., Ltd. | -2.06 Billion JPY | 77.431% |
| CellSeed Inc. | -2.01 Billion JPY | 76.822% |